SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-24-041930
Filing Date
2024-04-01
Accepted
2024-04-01 17:00:44
Documents
17
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm2410252d1_10ka.htm   iXBRL 10-K/A 113871
2 EXHIBIT 4.3 tm2410252d1_ex4-3.htm EX-4.3 30178
3 EXHIBIT 31.1 tm2410252d1_ex31-1.htm EX-31.1 3419
4 EXHIBIT 31.2 tm2410252d1_ex31-2.htm EX-31.2 3566
5 EXHIBIT 97 tm2410252d1_ex97.htm EX-97 21611
  Complete submission text file 0001104659-24-041930.txt   408696

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA clrb-20231231.xsd EX-101.SCH 3012
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE clrb-20231231_lab.xml EX-101.LAB 36257
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clrb-20231231_pre.xml EX-101.PRE 23744
21 EXTRACTED XBRL INSTANCE DOCUMENT tm2410252d1_10ka_htm.xml XML 6098
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36598 | Film No.: 24810608
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)